Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Reminder. Make a note. Well only ifn ya want to? Hehehe

$Citius Pharmaceuticals (CTXR.US)$ Upcoming catalyst for possibly superior gains? So ima share with my pals! Hehehe.                                            • A decision on the LYMPHIR BLA is expected on August 13, 2024, the FDA's assigned Prescription Drug User Fee Act (PDUFA) action date. If approved, Citius is preparing for LYMPHIR commercialization in 2024.
Considered a new biologic by the FDA, LYMPHIR would potentially be eligible for 12 years of exclusivity, if approved.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
3
+0
5
Translate
Report
5664 Views
Comment
Sign in to post a comment
2758Followers
29Following
38KVisitors
Follow